Everence Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,090	Closed	-$564	–	760
2024 Q2	$564	Buy	2,090 +470	+29%	+$137K	0.04%	353
2024 Q1	$560	Hold	1,620	–	–	0.04%	374
2023 Q4	$523K	Hold	1,620	–	–	0.04%	392
2023 Q3	$581	Buy	1,620 +900	+125%	+$347K	0.05%	340
2023 Q2	$269K	Hold	720	–	–	0.02%	562
2023 Q1	$345	Hold	720	–	–	0.03%	486
2022 Q4	$303	Buy	720 +110	+18%	+$44.4K	0.03%	537
2022 Q3	$254K	Sell	610 -70	-10%	-$34.9K	0.02%	574
2022 Q2	$337K	Buy	+680	New	+$354K	0.03%	473
2022 Q1	–	Sell	-580	Closed	-$438K	–	736
2021 Q4	$438K	Sell	580 -420	-42%	-$314K	0.03%	467
2021 Q3	$746K	Hold	1,000	–	–	0.06%	258
2021 Q2	$644K	Hold	1,000	–	–	0.05%	315
2021 Q1	$571K	Hold	1,000	–	–	0.05%	323
2020 Q4	$583K	Buy	1,000 +500	+100%	+$285K	0.06%	298
2020 Q3	$258K	Buy	+500	New	+$253K	0.03%	511